Objective-To investigate those characteristics of patients with rheumatoid arthritis (RA) that are associated with the development of rheumatoid vasculitis (RV). Methods-Demographic and clinical data of 69 patients who had been diagnosed as having RV were compared with those of 138 contemporaneous control patients with RA who were not suspected to have vasculitis. Vasculitis was confirmed histologically in 96% of the subjects with RV.
Abstract
Objective-To investigate those characteristics of patients with rheumatoid arthritis (RA) that are associated with the development of rheumatoid vasculitis (RV). Methods-Demographic and clinical data of 69 patients who had been diagnosed as having RV were compared with those of 138 contemporaneous control patients with RA who were not suspected to have vasculitis. Vasculitis was confirmed histologically in 96% of the subjects with RV. Results-Variables associated with the development of RV were: 1) male gender, presence of increased serum concentrations of rheumatoid factor, joint erosions, subcutaneous nodules, number of disease modifying antirheumatic drugs previously prescribed, treatment (ever) with D-penicillamine or azathioprine; 2) presence of nail fold lesions and any other extraarticular feature one year before the time of diagnosis of RV; 3) treatment with corticosteroids at the time of diagnosis of RV.
Conclusions-The development of RV is
associated with male gender, extraarticular features, and a severe course of RA as indicated by the presence of joint destruction and need for intensive treat Results Table 1 shows the basic characteristics of the study population. When compared with RA controls, RV cases were more often men, and more frequently had increased RF concentrations, joint erosions, and subcutaneous nodules. They were also more likely to have received previous treatment with DMARDs (in particular, intramuscular gold, D-penicilla- (4) 9 (7)** remains unexplained, though smoking habit, 6 (4) which is associated with male gender, has been 0 2 (1) suggested as a possible explanation.9 3 (2)
The association between RF and the de-21 (15) velopment of RV may be explained by the role The association of RV with subcutaneous nodules and nail fold lesions preceding the development of RV cannot be explained on the grounds that these lesions are a direct expression of vasculitis. These lesions are characterised histologically by perivascular mononuclear cells and intimal proliferation with intravascular thrombosisi-features that do not fulfill the established criteria for vasculitis. 3 However, the strong association found between the development of RV and subcutaneous nodules, in addition to nail fold lesions one year before the diagnosis of RV, provides additional support for the view that these lesions may be part of the disease spectrum of RV. The same may be true for other extra-articular features, such as serositis.
The association between RV and the number of DMARDs previously prescribed suggests that RV is a disease manifestation that marks the most severe spectrum of RA, rather than a separate disease entity. This hypothesis is supported by the association found between RV and indicators of a severe disease outcome the presence of joint erosions,14 subcutaneous nodules, and increased concentrations of RF. 15The concept of RV as a marker of severe RA implies that the pathogenetic mechanisms underlying RV are related to those that are specific for RA. The association found in the present study between D-penicillamine or azathioprine treatment and the development of RV is probably attributable to the fact that, in our centre, D-penicillamine and azathioprine are started late in the course of RA, after the failure of other DMARDs, and may be explained further by considering D-penicillamine and azathioprine as markers of a severe course of RA.
Treatment with corticosteroids has been suggested by some authors to be associated with the development of RV,7 though others have pointed out that seriously ill patients who develop vasculitis are likely to be treated with corticosteroids.' The latter observation is supported by the results of the present study, in which an association was found between the development of RV and corticosteroid treatment at the time of diagnosis, but not with ever having received corticosteroid treatment. 
